"Tumor Microenvironment" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The milieu surrounding neoplasms consisting of cells, vessels, soluble factors, and molecules, that can influence and be influenced by, the neoplasm's growth.
Descriptor ID |
D059016
|
MeSH Number(s) |
G04.366.500
|
Concept/Terms |
Tumor Microenvironment- Tumor Microenvironment
- Microenvironment, Tumor
- Microenvironments, Tumor
- Tumor Microenvironments
Cancer Microenvironment- Cancer Microenvironment
- Cancer Microenvironments
- Microenvironment, Cancer
- Microenvironments, Cancer
|
Below are MeSH descriptors whose meaning is more general than "Tumor Microenvironment".
Below are MeSH descriptors whose meaning is more specific than "Tumor Microenvironment".
This graph shows the total number of publications written about "Tumor Microenvironment" by people in this website by year, and whether "Tumor Microenvironment" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2009 | 0 | 1 | 1 |
2010 | 7 | 7 | 14 |
2011 | 16 | 25 | 41 |
2012 | 16 | 16 | 32 |
2013 | 14 | 21 | 35 |
2014 | 20 | 19 | 39 |
2015 | 20 | 30 | 50 |
2016 | 40 | 36 | 76 |
2017 | 23 | 49 | 72 |
2018 | 22 | 54 | 76 |
2019 | 34 | 68 | 102 |
2020 | 43 | 91 | 134 |
2021 | 35 | 112 | 147 |
2022 | 15 | 156 | 171 |
2023 | 6 | 154 | 160 |
2024 | 0 | 34 | 34 |
To return to the timeline,
click here.
Below are the most recent publications written about "Tumor Microenvironment" by people in Profiles.
-
The roles of ferroptosis in cancer: Tumor suppression, tumor microenvironment, and therapeutic interventions. Cancer Cell. 2024 Apr 08; 42(4):513-534.
-
Peritoneal Microenvironment Promotes Appendiceal Adenocarcinoma Growth: A Multi-omics Approach Using Patient-Derived Xenografts. Mol Cancer Res. 2024 Apr 02; 22(4):329-336.
-
Exploring Ferroptosis-Inducing Therapies for Cancer Treatment: Challenges and Opportunities. Cancer Res. 2024 Apr 01; 84(7):961-964.
-
Chromatin Remodelers Are Regulators of the Tumor Immune Microenvironment. Cancer Res. 2024 Apr 01; 84(7):965-976.
-
Oncolytic adenoviruses and immunopeptidomics: a?convenient marriage. Mol Oncol. 2024 Apr; 18(4):781-784.
-
LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): results from arm 1 of a non-randomised, single-centre, phase 1/2 study. Lancet Oncol. 2024 Apr; 25(4):488-500.
-
Let-7i enhances anti-tumour immunity and suppresses ovarian tumour growth. Cancer Immunol Immunother. 2024 Mar 30; 73(5):80.
-
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment. Cell. 2024 Mar 28; 187(7):1617-1635.
-
Identification of Nonfunctional Alternatively Spliced Isoforms of STING in Human Acute Myeloid Leukemia. Cancer Res Commun. 2024 Mar 25; 4(3):911-918.
-
ICOS costimulation in combination with CTLA-4 blockade remodels tumor-associated macrophages toward an antitumor phenotype. J Exp Med. 2024 Apr 01; 221(4).